病人在没有许可证的情况下发现负担得起的肥胖症药物的来源后面临不确定性。 Patients face uncertainty after discovering their source of affordable obesity drugs was unlicensed.

从网站购买负担得起的肥胖药品的病人,在发现复方药店缺乏必要的许可证后,现在无法确定他们的选择。 Patients who bought affordable obesity drugs from a website are now unsure of their options after discovering the compounding pharmacy lacked the necessary license. 这些病人储存了替代的GLP-1药物,引起了人们对购买这些药物的合法性和安全性的担忧。 These patients stockpiled alternative GLP-1 drugs, raising concerns about the legality and safety of their purchases. NPR的Sydney Lupkin报告的情况使患者和医疗设施处于不确定状态。 The situation, reported by NPR's Sydney Lupkin, leaves both patients and medical facilities in uncertainty.